Concepedia

Morten Rühwald

MR

Statistics

Publications

91

Citations

4.7K

H-Index

40

Active since

2001

Affiliations

FIND(Current)

Statens Serum Institut

University of Cape Town

Heidelberg University

Hvidovre Hospital

Morten Rühwald is an author at FIND specializing in infectious diseases, tuberculosis diagnostic testing, and tuberculosis diagnosis.

ORCID

Publications per year

2001–2025

91

Publications

91

A novel liposomal adjuvant system, CAF01, promotes long-lived Mycobacterium tuberculosis-specific T-cell responses in human

Jaap T. van Dissel, Simone A. Joosten, Søren T. Hoff et al. · Vaccine · 2014 · 243 citations · Full text

, , +17

Latent Tuberculosis in HIV positive, diagnosed by the M. Tuberculosis Specific Interferon-γ test

Inger Brock, Morten Rühwald, Bettina Lundgren et al. · Respiratory Research · 2006 · 211 citations · Full text

, , +15

Safety and immunogenicity of the chlamydia vaccine candidate CTH522 adjuvanted with CAF01 liposomes or aluminium hydroxide: a first-in-human, randomised, double-blind, placebo-controlled, phase 1 trial

Sonya Abraham, Helene Bæk Juel, Peter Fibiger Bang et al. · The Lancet Infectious Diseases · 2019 · 205 citations

, , +16

Evaluating the potential of IP-10 and MCP-2 as biomarkers for the diagnosis of tuberculosis

Morten Rühwald, Thomas Bodmer, C Maier et al. · European Respiratory Journal · 2008 · 193 citations · Full text

, , +17

Antigen Availability Shapes T Cell Differentiation and Function during Tuberculosis

Albanus O. Moguche, Munyaradzi Musvosvi, Adam Penn‐Nicholson et al. · Cell Host & Microbe · 2017 · 188 citations · Full text

, , +10

1–5 of 91